technetium tc 99m sestamibi has been researched along with Apolipoprotein B-100, Familial Defective in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, L; Jiao, J; Mi, HZ; Wang, LY; Wang, Q; Yang, SW | 1 |
| Lupattelli, G; Palumbo, B; Sinzinger, H | 1 |
2 other study(ies) available for technetium tc 99m sestamibi and Apolipoprotein B-100, Familial Defective
| Article | Year |
|---|---|
Use of (18)F-FDG PET and MPI with (99m)Tc-MIBI in a patient with delayed diagnosis of homozygous familial hypercholesterolemia.
Topics: Adult; Delayed Diagnosis; Fluorodeoxyglucose F18; Humans; Hyperlipoproteinemia Type II; Male; Myocardial Perfusion Imaging; Positron-Emission Tomography; Radiography; Technetium Tc 99m Sestamibi | 2015 |
Statin induced myopathy does not show up in MIBI scintigraphy.
Topics: Adult; Anticholesteremic Agents; Atorvastatin; Breast Neoplasms; Fatty Acids, Monounsaturated; Female; Fluvastatin; Heptanoic Acids; Heterozygote; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Indoles; Lovastatin; Male; Middle Aged; Muscle, Skeletal; Muscular Diseases; Pain; Pravastatin; Pyridines; Pyrroles; Radionuclide Imaging; Radiopharmaceuticals; Simvastatin; Technetium Tc 99m Sestamibi | 2001 |